No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab / administration & dosage
-
Doxorubicin / administration & dosage
-
Doxorubicin / analogs & derivatives
-
Drug Administration Schedule
-
Drug Resistance, Neoplasm*
-
Female
-
Humans
-
Kaplan-Meier Estimate
-
Middle Aged
-
Neoplasm Grading
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Staging
-
Ovarian Neoplasms / drug therapy*
-
Ovarian Neoplasms / pathology
-
Paclitaxel / administration & dosage
-
Platinum Compounds / pharmacology*
-
Polyethylene Glycols / administration & dosage
-
Prognosis
-
Risk Factors
-
Topotecan / administration & dosage
-
Treatment Outcome
Substances
-
Platinum Compounds
-
liposomal doxorubicin
-
Bevacizumab
-
Polyethylene Glycols
-
Topotecan
-
Doxorubicin
-
Paclitaxel